Drug Shortage Report for TEVA-LENOLTEC NO. 3
| Report ID | 112376 |
| Drug Identification Number | 00653276 |
| Brand name | TEVA-LENOLTEC NO. 3 |
| Common or Proper name | LENOLTEC NO.3 TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CAFFEINE CODEINE PHOSPHATE ACETAMINOPHEN |
| Strength(s) | 15MG 30MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-15 |
| Estimated end date | 2020-07-31 |
| Actual end date | 2020-07-29 |
| Shortage status | Resolved |
| Updated date | 2020-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-07-30 | French | Compare |
| v7 | 2020-07-30 | English | Compare |
| v6 | 2020-06-25 | French | Compare |
| v5 | 2020-06-25 | English | Compare |
| v4 | 2020-05-29 | French | Compare |
| v3 | 2020-05-29 | English | Compare |
| v2 | 2020-04-16 | French | Compare |
| v1 | 2020-04-16 | English | Compare |
Showing 1 to 8 of 8